What Is DSIP?
DSIP (Delta Sleep-Inducing Peptide) is classified as a sleep peptide peptide. Modulates sleep-wake cycle. Promotes delta-wave (deep) sleep phases. Interacts with GABA, serotonin, and opioid pathways.
It is extensively evaluated in laboratory and clinical settings for its potential to drive improved sleep quality, stress reduction. Researchers target DSIP for its ability to interact with specific cellular and molecular pathways, making it a compound of significant interest across multiple therapeutic domains.
Limited modern data. Most studies from the 1980s-90s. Safety profile incompletely defined.
How Does DSIP Work?
Modulates sleep-wake cycle. Promotes delta-wave (deep) sleep phases. Interacts with GABA, serotonin, and opioid pathways.
At the molecular level, DSIP operates through pathways characteristic of the Sleep Peptide class. By interacting with target receptors and downstream signaling cascades, the compound initiates biological responses associated with improved sleep quality, stress reduction.
Expected Research Timeline
Weeks 2–4
More restful sleep; potential pain modulation via opioid pathways
Months 2–3
Circadian rhythm stabilization; stress resilience improvement
Long-Term
Effects require cycling; cumulative normalization of sleep architecture
What Does the Research Say?
The following are key findings from peer-reviewed studies on DSIP, indexed on PubMed and equivalent databases:
[1]DSIP delta sleep promotion in chronic insomniacs
Schneider-Helmert & Schoenenberger: DSIP administered IV to chronic insomniacs decreased nocturnal awakenings, reduced sleep latency, and increased total NREM sleep time.
Evidence: moderate[2]DSIP normalizes sleep in elderly insomniacs
DSIP normalizes sleep architecture in middle-aged and elderly chronic insomniacs, with improvements maintained during follow-up week after treatment cessation.
Evidence: moderate[3]Synthetic DSIP improves disturbed human sleep
Schneider-Helmert (Experientia): Longer sleep duration, fewer interruptions, and increased REM sleep documented without daytime sedation or side effects.
Evidence: moderate[4]Repeated DSIP administration and sleep structure normalization
Study demonstrating that repeated DSIP administration produces cumulative buildup effects, progressively normalizing disturbed sleep patterns.
Evidence: moderateSafety & Side Effects
Limited modern data. Most studies from the 1980s-90s. Safety profile incompletely defined.
| Side Effect | Incidence | Severity |
|---|---|---|
| Headache | ~3% of users | mild |
| Morning grogginess (wrong timing) | ~5% of users | mild |
FDA Status: Not Approved for Human Therapeutic Use
DSIP is not currently FDA-approved for human use. It is available for research purposes only. Always consult a licensed healthcare provider.
How Is DSIP Used?
Route
SubQ
Dose Range
100–100 mcg
Frequency
7x/wk
Cycle
4–4 wk
Timing: 30 min before bed
Notes: Very short half-life. Take immediately before sleep. Cycle to avoid tolerance.
All dosing information reflects parameters reported in published research literature and is not intended as clinical guidance. Usage of any peptide should be supervised by a qualified healthcare professional.
DSIP vs. Related Compounds
| Compound | Primary Use |
|---|---|
| DSIP(this page) | Improved sleep quality, stress reduction |
| Epitalon | Anti-aging, longevity, sleep |
| Ipamorelin | GH release, muscle growth, recovery without cortisol spike |
| Selank | Anxiety reduction, mental clarity, mood |
Where to Source DSIP for Research
Purchasing ultra-high purity, laboratory-grade peptides is critical for verifiable research. We only recommend vendors providing independent, third-party HPLC Certificates of Analysis (COA).
Disclosure: PeptiDex may earn a commission from purchases. This does not affect our recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
Frequently Asked Questions
What is DSIP?
DSIP is a sleep peptide peptide. Modulates sleep-wake cycle. Promotes delta-wave (deep) sleep phases. Interacts with GABA, serotonin, and opioid pathways.
What are the primary research benefits of DSIP?
Published research identifies primary mechanisms targeting: Improved sleep quality, stress reduction. These findings come from 4+ peer-reviewed studies indexed in our database.
What is the half-life of DSIP?
In published pharmacokinetic data, DSIP demonstrates a half-life of approximately 0.13 hours.
Is DSIP FDA approved?
DSIP is not currently FDA-approved for human therapeutic use. It is classified as a research compound and is studied under investigational protocols. Always consult a healthcare provider.
What are common side effects of DSIP?
Reported side effects in published literature include Headache (~3% of users), Morning grogginess (wrong timing) (~5% of users). Most are classified as mild in severity.
How is DSIP administered?
In research settings, DSIP is typically administered via SubQ. Very short half-life. Take immediately before sleep. Cycle to avoid tolerance.
Sources
- DSIP delta sleep promotion in chronic insomniacs. View on PubMed
- DSIP normalizes sleep in elderly insomniacs. View on PubMed
- Synthetic DSIP improves disturbed human sleep. View on PubMed
- Repeated DSIP administration and sleep structure normalization. View on PubMed